Assessment of peppermint extract effect on colonoscopy quality

Assessment of peppermint extract effect on colonoscopy quality in patients referring to Urmia Imam Khomeini hospital

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201204049599N5

Enrollment

128

Registered

2021-06-14

Start date

2021-07-26

Completion date

Unknown

Last updated

2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy.

Interventions

Intervention 1: Intervention group: 50 cc of peppermint extract in various areas of the colon during colonoscopy will be injected into the large intestine through the working channel of the colonoscop

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 65 years, not consuming antispasmodics, suspicion of intestinal polyps, large bowel diseases, unknown origin gastrointestinal bleeding

Exclusion criteria

Exclusion criteria: Irritable Bowel Syndrome, lack of having mental health and full consciousness, consumption of anti-anxiety and painkillers, having a history of allergy to any drug

Design outcomes

Primary

Measure	Time frame
Total time of the procedure. Timepoint: During Colonoscopy. Method of measurement: Minute.	—

Secondary

Measure	Time frame
Pain. Timepoint: During Colonoscopy procedure. Method of measurement: Score based on visual analog scale (VAS).;Time to reach Cecum. Timepoint: During colonoscopy. Method of measurement: Minute.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Reza Pashaei

Oroumia University of Medical Sciences

pashaee.m@umsu.ac.ir+98 44 3346 9931

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026